Carregant...
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory...
Guardat en:
| Publicat a: | J Cardiovasc Transl Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7892683/ https://ncbi.nlm.nih.gov/pubmed/32222950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-020-09994-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|